诺华今日宣布，Coartem ® （蒿甲醚-苯芴醇）Baby已获瑞士治疗产品管理局（Swissmedic）批准，成为首个用于新生儿及婴幼儿的疟疾治疗药物。该款新药在部分国家也被称为Riamet ® Baby，由诺华与MedicinesforMalariaVenture（MMV）合作开发，用于治疗疟疾这种可能致命的蚊媒疾病。

VIENTIANE, July 7 (Xinhua) -- Laos reported 2,614 cases of dengue fever in the first half of 2025, marking a significant decrease from the 5,192 cases recorded during the same period in 2024.